EMA — authorised 20 November 2014
- Marketing authorisation holder: Boehringer Ingelheim International GmbH
- Status: approved
🇪🇺 Ofev in European Union
EMA authorised Ofev on 20 November 2014
Marketing authorisation
Ofev in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in European Union
Frequently asked questions
Is Ofev approved in European Union?
Yes. EMA authorised it on 20 November 2014.
Who is the marketing authorisation holder for Ofev in European Union?
Boehringer Ingelheim International GmbH holds the EU marketing authorisation.